eXTReMe Tracker
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter February 2009

Gene Therapy Net Banner
Conference update
- 18 – 21 March 2009, Fifth International Meeting on Replicating Oncolytic Virus Therapeutics
- 27 – 29 March 2009, Cellular Therapy of Cancer Symposium
- 4 May 2009, 6th Annual Conference of the Israeli Society of Gene and Cell Therapy (ISGCT)
6th Australasian Gene Therapy Society Meeting
The conference (April 29th - May 1st, 2009) will be held at the Royal Prince Alfred Hospital Kerry Packer Education Centre, Sydney. A select group of international and national speakers will cover key areas in gene therapy research, including several new approaches involving novel vectors and reagents. We are expecting up to 200 professionals to attend the conference, providing an excellent opportunity to network and develop collaborations.
Registration is now open. Register now to take advantage of the Early Bird rate. Early Bird closes on Friday 13th of March 2007. Click here to download registration details.
See attachment to view a copy of the conference second announcement. http://www.agts.org.au
News: Ark Therapeutics Files Cerepro Application for European Marketing Authorisation
Ark Therapeutics announced that the Marketing Authorisation Application (MAA) for Cerepro, Ark’s novel gene-based therapy for operable malignant glioma (brain cancer) which was recently filed with the EMEA, has cleared the validation stage. The Cerepro MAA application now commences formal review via the centralised procedure which is the standard route for all advanced therapies. Cerepro was originally filed for marketing approval in late 2005 and was reviewed by the EMEA with reliance on Phase II data. The review established that more clinical data were needed to confirm the findings and to demonstrate the reproducibility of the results in a larger multi-centre clinical trial. The Phase III study of Cerepro, completed in July 2007, showed that treatment with Cerepro resulted in a significant therapeutic benefit, supporting the results of the Phase II clinical studies. Thu, 8 Jan 2009.
Quiz: How much do you know about gene therapy?
Test your knowledge about gene therapy. Take this quiz and answer ten questions in each of three difficulty levels. The correct answer is given after each question.

Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines, www.genetherapynet.com